RBC Capital Maintains Sector Perform on Bio-Techne, Lowers Price Target to $83
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has maintained a 'Sector Perform' rating on Bio-Techne (NASDAQ:TECH) and lowered the price target from $85 to $83.
November 01, 2023 | 4:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RBC Capital has maintained its 'Sector Perform' rating on Bio-Techne and lowered the price target from $85 to $83.
The lowering of the price target by RBC Capital indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on Bio-Techne's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100